Results 281 to 290 of about 3,128,729 (335)

Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma. [PDF]

Discov Oncol
Abana CO, Garden AS, Brandon Gunn G, Chronowski GM, Mohamed ASR, Frankart AJ, Geier N, Bahig H, Barbon CEA, Hutcheson K, Takiar V, Fuller CD, Frank SJ, Rosenthal DI, Phan J.   +14 more
europepmc   +1 more source

Data Sheet 1_Electronic patient-reported outcome systems and capabilities in cancer care: a systematic review.docx

Hosna Salmani (9725579), Somayeh Nasiri (15968859), Mahdi Alemrajabi (10949408), Maryam Ahmadi (4183186)   +3 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Correction to "Patient-Reported Outcomes Among an Observational Cohort of Individuals With Chronic Low Back Pain". [PDF]

JOR Spine
europepmc   +1 more source

ProAE: an R package for graphical tools and standardized analysis of patient-reported outcomes and adverse events data. [PDF]

BMC Med Inform Decis Mak
Langlais B, Noble B, Fruth B, Truman M, Mazza GL, Ginos B, Mead-Harvey C, Lee M, Yee C, Rogak L, Meek E, Deal AM, Peipert JD, Thanarajasingam G, Basch E, Dueck AC.   +15 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Using an electronic frailty index and patient reported outcomes to predict sarcopenia risk. [PDF]

Sci Rep
Altherr CA, Luo X, Ding H, Liu Z, Warden SJ, Moorthi RN, Imel EA.   +6 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias. [PDF]

J Cancer Res Clin Oncol
Crodel CC, Kohnle C, Radsak MP, Nückel H, Jilg S, Hochhaus A, Heidel FH, Hübner J.   +7 more
europepmc   +1 more source